Latest Ind Swift Laboratories stock price

Ind Swift Laboratories P/E Ratio

INDSWFTLAB • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
3.18
Low Valuation
Very Low - Potentially undervalued or facing challenges

Current Valuation Metrics

P/E Ratio 3.18
Current Price ₹90.37
EPS (TTM) ₹37.25
Exchange NSE

Valuation Signal

Signal Undervalued
Historical Avg 12.24
Historical Range 12.24 - 12.24
Percentile 0.0%

Sector Context

Sector Average 53.78
Sector Median 31.12
Sector Rank #2 of 131
Sector Percentile 1.5%

Earnings Breakdown (TTM)

TTM EPS ₹35.31
Sept 2025 ₹1.00
Mar 2025 ₹32.96

Key P/E Ratio Insights for Ind Swift Laboratories

  • Stock appears undervalued with PE of 3.18, suggesting potential buying opportunity
  • Current PE is 74.0% below historical average
  • Trading at discount to sector average PE of 53.78

View the INDSWFTLAB equity price for detailed stock performance.

P/E Ratio Historical Trend for Ind Swift Laboratories

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2020 12.24 5.0 ₹61.20 BSE Low

Sector P/E Ratio Comparison

Comparing Ind Swift Laboratories with other companies in Healthcare sector
Sector Average
53.78
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 1.5 ₹51 Low
Murae Organisor MURAE 3.86 ₹55 Low
Fermenta Biotech FERMENTA 9.01 ₹1,010 Low
Zenith Drugs ZENITHDRUG 9.06 ₹84 Low
Galaxy Medicare GML 9.5 ₹32 Low
Balaxi Pharmaceuticals BALAXI 10.06 ₹139 Low
Natco Pharma NATCOPHARM 10.8 ₹17,006 Low
Vasundhara Rasayans VRL 11.3 ₹51 Low
Mohini Health & Hygiene MHHL 11.84 ₹69 Low
Lincoln Pharmaceuticals LINCOLN 12.02 ₹974 Low